Scott Langille – Principal, Western Ontario
Scott is a senior executive with extensive experience in corporate and operational finance, with deep knowledge of the cannabis industry and all facets of life sciences in Canada and the US, including brand and generic pharmaceuticals, medical devices and biotechnology. He has a highly developed ability to manage change, and has proven success with business start-ups, acquisitions and mergers. Prior to joining the team, Scott was CFO at Wayland Group, a vertically integrated cultivator and processor of cannabis, where he was a member of the senior management team which raised $166M and achieved a peak market cap of $875M. Scott was also CFO and co-owner of Tribute Pharmaceuticals, which was founded in mid-2000’s and sold to Pozen in 2015 for US $146M. He also held the position of CFO at Virexx Medical (a public biotechnology company) and VP at Biovail Pharmaceuticals in North Carolina.
Scott holds a professional accounting designation and an MBA from the University of Toronto.